Literature DB >> 29024646

The Epstein-Barr Virus Regulome in Lymphoblastoid Cells.

Sizun Jiang1, Hufeng Zhou1, Jun Liang1, Catherine Gerdt2, Chong Wang1, Liangru Ke3, Stefanie C S Schmidt1, Yohei Narita1, Yijie Ma1, Shuangqi Wang4, Tyler Colson2, Benjamin Gewurz2, Guoliang Li4, Elliott Kieff5, Bo Zhao6.   

Abstract

Epstein-Barr virus (EBV) transforms B cells to continuously proliferating lymphoblastoid cell lines (LCLs), which represent an experimental model for EBV-associated cancers. EBV nuclear antigens (EBNAs) and LMP1 are EBV transcriptional regulators that are essential for LCL establishment, proliferation, and survival. Starting with the 3D genome organization map of LCL, we constructed a comprehensive EBV regulome encompassing 1,992 viral/cellular genes and enhancers. Approximately 30% of genes essential for LCL growth were linked to EBV enhancers. Deleting EBNA2 sites significantly reduced their target gene expression. Additional EBV super-enhancer (ESE) targets included MCL1, IRF4, and EBF. MYC ESE looping to the transcriptional stat site of MYC was dependent on EBNAs. Deleting MYC ESEs greatly reduced MYC expression and LCL growth. EBNA3A/3C altered CDKN2A/B spatial organization to suppress senescence. EZH2 inhibition decreased the looping at the CDKN2A/B loci and reduced LCL growth. This study provides a comprehensive view of the spatial organization of chromatin during EBV-driven cellular transformation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDKN2A/B; ChIA-PET; EBV regulome; EBV super-enhancers; Epstein-Barr virus; MYC

Mesh:

Substances:

Year:  2017        PMID: 29024646      PMCID: PMC5662195          DOI: 10.1016/j.chom.2017.09.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  73 in total

1.  Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.

Authors:  J Finke; M Rowe; B Kallin; I Ernberg; A Rosén; J Dillner; G Klein
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.

Authors:  Seiji Maruo; Yi Wu; Taku Ito; Teru Kanda; Elliott D Kieff; Kenzo Takada
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

3.  Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.

Authors:  Anqi Wang; Rene Welch; Bo Zhao; Tram Ta; Sündüz Keleş; Eric Johannsen
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 4.  Enhancer function: new insights into the regulation of tissue-specific gene expression.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  Nat Rev Genet       Date:  2011-03-01       Impact factor: 53.242

5.  An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions.

Authors:  Aaron Arvey; Italo Tempera; Kevin Tsai; Horng-Shen Chen; Nadezhda Tikhmyanova; Michael Klichinsky; Christina Leslie; Paul M Lieberman
Journal:  Cell Host Microbe       Date:  2012-08-16       Impact factor: 21.023

6.  Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.

Authors:  Lenka Skalska; Robert E White; Melanie Franz; Michaela Ruhmann; Martin J Allday
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

7.  Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.

Authors:  Daniel Portal; Hufeng Zhou; Bo Zhao; Peter V Kharchenko; Elizabeth Lowry; Limsoon Wong; John Quackenbush; Dustin Holloway; Sizun Jiang; Yong Lu; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

8.  The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.

Authors:  Shuvomoy Banerjee; Jie Lu; Qiliang Cai; Abhik Saha; Hem Chandra Jha; Richard Kuo Dzeng; Erle S Robertson
Journal:  PLoS Pathog       Date:  2013-05-02       Impact factor: 6.823

9.  TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.

Authors:  Hannah Greenfeld; Kaoru Takasaki; Michael J Walsh; Ina Ersing; Katharina Bernhardt; Yijie Ma; Bishi Fu; Camille W Ashbaugh; Jackson Cabo; Sarah B Mollo; Hufeng Zhou; Shitao Li; Benjamin E Gewurz
Journal:  PLoS Pathog       Date:  2015-05-21       Impact factor: 6.823

10.  Easy quantitative assessment of genome editing by sequence trace decomposition.

Authors:  Eva K Brinkman; Tao Chen; Mario Amendola; Bas van Steensel
Journal:  Nucleic Acids Res       Date:  2014-10-09       Impact factor: 16.971

View more
  43 in total

1.  Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis.

Authors:  Thomas Sommermann; Tomoharu Yasuda; Jonathan Ronen; Tristan Wirtz; Timm Weber; Ulrike Sack; Rebecca Caeser; Jingwei Zhang; Xun Li; Van Trung Chu; Anna Jauch; Kristian Unger; Daniel J Hodson; Altuna Akalin; Klaus Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-10       Impact factor: 11.205

2.  Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines.

Authors:  Hiroki Hosoi; Akiko Niibori-Nambu; Giselle Sek Suan Nah; Avinash Govind Bahirvani; Michelle Meng Huang Mok; Takaomi Sanda; Alan Prem Kumar; Daniel G Tenen; Yoshiaki Ito; Takashi Sonoki; Motomi Osato
Journal:  Gene       Date:  2021-01-12       Impact factor: 3.688

3.  Robust imaging and gene delivery to study human lymphoblastoid cell lines.

Authors:  Lachlan A Jolly; Ying Sun; Renée Carroll; Claire C Homan; Jozef Gecz
Journal:  J Hum Genet       Date:  2018-06-20       Impact factor: 3.172

4.  TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.

Authors:  Chong Wang; Sizun Jiang; Luyao Zhang; Difei Li; Jun Liang; Yohei Narita; Isabella Hou; Qian Zhong; Benjamin E Gewurz; Mingxiang Teng; Bo Zhao
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

5.  MYC Controls the Epstein-Barr Virus Lytic Switch.

Authors:  Rui Guo; Chang Jiang; Yuchen Zhang; Apurva Govande; Stephen J Trudeau; Fang Chen; Christopher J Fry; Rishi Puri; Emma Wolinsky; Molly Schineller; Thomas C Frost; Makda Gebre; Bo Zhao; Lisa Giulino-Roth; John G Doench; Mingxiang Teng; Benjamin E Gewurz
Journal:  Mol Cell       Date:  2020-04-20       Impact factor: 17.970

6.  RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.

Authors:  Chong Wang; Difei Li; Luyao Zhang; Sizun Jiang; Jun Liang; Yohei Narita; Isabella Hou; Qian Zhong; Zeguang Zheng; Haipeng Xiao; Benjamin E Gewurz; Mingxiang Teng; Bo Zhao
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

Review 7.  Epigenetic crossroads of the Epstein-Barr virus B-cell relationship.

Authors:  Thomas C Frost; Benjamin E Gewurz
Journal:  Curr Opin Virol       Date:  2018-09-15       Impact factor: 7.090

Review 8.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

9.  Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.

Authors:  Yonggang Pei; Josiah Hiu-Yuen Wong; Hem Chandra Jha; Tian Tian; Zhi Wei; Erle S Robertson
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

Review 10.  Utilization of Host Cell Chromosome Conformation by Viral Pathogens: Knowing When to Hold and When to Fold.

Authors:  Kinjal Majumder; Abigail J Morales
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.